ContributorsPublishersAdvertisers

After high hopes for Merck’s COVID-19 pill, Wall Street now expects a ‘tepid’ authorization

MarketWatch
MarketWatch
 2021-12-01
Cover picture for the article

It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month but it's expected to be restricted to certain high-risk...

www.marketwatch.com

Comments / 0

Comments / 0